Abstract
THE CD40 surface molecule is a 277-amino-acid glycoprotein expressed on B lymphocytes, epithelial cells and some carcinoma cell lines. Monoclonal antibodies against CD40 mediate a variety of effects on B lymphocytes, including induction of intercellular adhesion1,2, short- and long-term proliferation3–5, differentiation6,7 and enhanced tyrosine phosphorylation of proteins8. In addition, germinal centre centrocytes are prevented from undergoing apop-tosis by activation through CD40 and receptor for antigen9. These data indicate that CD40 could be a receptor for an unknown ligand with important functions in B-cell development and activation. This hypothesis is strengthened by the homology of the extracellular region of the CD40 molecule10with a family of cell-surface glycoproteins11,12that includes the receptors for nerve growth factor13,14 and tumour necrosis factor11,15,16. Here we report the cloning of a ligand for CD40 that is expressed on the cell surface of activated T cells and mediates B-cell proliferation in the absence of co-stimulus, as well as IgE production in the presence of interIeukin-4.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Valle, A. et al. Eur. J. Immun. 19, 1463–1467 (1989).
Barrett, T. B., Shu, G. & Clark, E. A. J. Immun. 146, 1722–1729 (1991).
Clark, E. A. & Ledbetter, J. A. Proc. natn. Acad. Sci. U.S.A. 83, 4494–4498 (1986).
Paulie, S. et al. J. Immun. 142, 590–595 (1989).
Banchereau, J., de Paoli, P., Valle, A., Garcia, E. & Rousset, F. Science 251, 70–72 (1991).
Jabara, H. H., Fu, S. M., Geha, R. S. & Vercelli, D. J. exp. Med. 172, 1861–1864 (1990).
Zhang, K., Clark, E. A. & Saxon, A. J. Immun. 146, 1836–1842 (1991).
Uckun, F. M. et al. J. biol. Chem. 266, 17478–17485 (1991).
Liu, Y. J. et al. Nature 342, 929–931 (1989).
Stamenkovic, I., Clark, E. A. & Seed, B. EMBO J. 8, 1403–1410 (1989).
Smith, C. A. et al. Science 248, 1019–1023 (1990).
Smith, C. A. et al. Biochem. biophys. Res. Commun. 176, 335–342 (1991).
Johnson, D. et al. Cell 47, 545–554 (1986).
Radeke, M. J., Misko, T. P., Hsu, C., Herzenberg, L. A. & Shooter, E. M. Nature 325, 593–597 (1987).
Loetscher, H. et al. Cell 61, 351–359 (1990).
Schall, T. J. et al. Cell 61, 361–370 (1990).
Fanslow, W. C. et al. J. Immun. (in the press).
McMahan, C. J. et al. EMBO J. 10, 2821–2832 (1991).
Kriegler, M., Perez, C., DeFay, K., Albert, I. & Lu, S. D. Cell 53, 45–53 (1988).
Devereux, J., Haeberli, P. & Smithies, O. Nucleic Acids Res. 12, 387–395 (1984).
Coffman, R. L. et al. Immunol. Rev. 102, 5–28 (1988).
Leo, O., Foo, M., Sachs, D. H., Samelson, L. E. & Bluestone, J. A. Proc. natn. Acad. Sci. U.S.A. 84, 1374–1378 (1987).
Spriggs, M. K. et al. J. biol. Chem. 265, 22499–22505 (1990).
Braesch-Anderson, S. et al. J. Immun. 142, 562–567 (1989).
Thomas, G., Thorne, B. A. & Hruby, D. E. A. Rev. Physiol. 50, 323–332 (1988).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Armitage, R., Fanslow, W., Strockbine, L. et al. Molecular and biological characterization of a murine ligand for CD40. Nature 357, 80–82 (1992). https://doi.org/10.1038/357080a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/357080a0
This article is cited by
-
Predictive value of soluble CD40L combined with APACHE II score in elderly patients with sepsis in the emergency department
BMC Anesthesiology (2024)
-
Thromboinflammatory challenges in stroke pathophysiology
Seminars in Immunopathology (2023)
-
Engaging innate immunity in HIV-1 cure strategies
Nature Reviews Immunology (2022)
-
Mechanisms of CD40-dependent cDC1 licensing beyond costimulation
Nature Immunology (2022)
-
Novel targeted mtLivin nanoparticles treatment for disseminated diffuse large B-cell lymphoma
Oncogene (2021)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.